Skip to main content

and
  1. Article

    Open Access

    Sodium glucose co-transporter-2 inhibitors in intensive care unit patients with type 2 diabetes: a pilot case control study

    Sodium glucose co-transporter-2 (SGLT2) inhibitors improve long-term cardiovascular and renal outcomes in individuals with type 2 diabetes. However, the safety of SGLT2 inhibitors in ICU patients with type 2 d...

    Johan Mårtensson, Salvatore Lucio Cutuli, Eduardo A. Osawa in Critical Care (2023)

  2. Article

    Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

    We assessed long-term outcomes of dexamethasone 12 mg versus 6 mg given daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia.

    Anders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch in Intensive Care Medicine (2022)

  3. Article

    Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

    We compared dexamethasone 12 versus 6 mg daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the international, randomised, blinded COVID STEROID 2 trial. In t...

    Anders Granholm, Marie Warrer Munch, Sheila Nainan Myatra in Intensive Care Medicine (2022)

  4. Article

    Open Access

    The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial

    Septic shock is associated with decreased vasopressor responsiveness. Experimental data suggest that central alpha2-agonists like dexmedetomidine (DEX) increase vasopressor responsiveness and reduce catecholam...

    Luca Cioccari, Nora Luethi, Michael Bailey, Yahya Shehabi, Belinda Howe in Critical Care (2020)

  5. Article

    Correction to: Continual hemodynamic monitoring with a single-use transesophageal echocardiography probe in critically ill patients with shock: a randomized controlled clinical trial

    The original version of this article unfortunately contained a mistake.

    Tobias M. Merz, Luca Cioccari, Pascal M. Frey, Andreas Bloch in Intensive Care Medicine (2019)

  6. No Access

    Article

    Continual hemodynamic monitoring with a single-use transesophageal echocardiography probe in critically ill patients with shock: a randomized controlled clinical trial

    Mortality in circulatory shock is high. Enhanced resolution of shock may improve outcomes. We aim to determine whether adding hemodynamic monitoring with continual transesophageal echocardiography (hTEE) to us...

    Tobias M. Merz, Luca Cioccari, Pascal M. Frey, Andreas Bloch in Intensive Care Medicine (2019)

  7. No Access

    Article

    Small volume resuscitation with 20% albumin in intensive care: physiological effects

    We set out to assess the resuscitation fluid requirements and physiological and clinical responses of intensive care unit (ICU) patients resuscitated with 20% albumin versus 4–5% albumin.

    Johan Mårtensson, Shailesh Bihari, Jonathan Bannard-Smith in Intensive Care Medicine (2018)

  8. Article

    Open Access

    Correction to: Effects of hemodynamic monitoring using a single-use transesophageal echocardiography probe in critically ill patients – study protocol for a randomized controlled trial

    Following publication of the original article [1], the authors reported an error in the sample size calculation.

    Luca Cioccari, Bjoern Zante, Andreas Bloch, David Berger, Andreas Limacher in Trials (2018)

  9. Article

    Open Access

    Effects of hemodynamic monitoring using a single-use transesophageal echocardiography probe in critically ill patients – study protocol for a randomized controlled trial

    Hemodynamic instability is one of the leading causes of intensive care unit (ICU) admission. Early stabilization of hemodynamics is associated with improved outcome. The monitoring used to guide hemodynamic su...

    Luca Cioccari, Bjoern Zante, Andreas Bloch, David Berger, Andreas Limacher in Trials (2018)

  10. Article

    Open Access

    The effect of insulin administration on c-peptide in critically ill patients with type 2 diabetes

    In critically ill patients with permissive hyperglycemia, it is uncertain whether exogenous insulin administration suppresses or enhances c-peptide secretion (a marker of pancreatic beta-cell response). We aim...

    Marco Crisman, Luca Lucchetta, Nora Luethi, Luca Cioccari in Annals of Intensive Care (2017)

  11. Article

    Open Access

    Prevalence of ketosis, ketonuria, and ketoacidosis during liberal glycemic control in critically ill patients with diabetes: an observational study

    It is uncertain whether liberal glucose control in critically ill diabetic patients leads to increased ketone production and ketoacidosis. Therefore, we aimed to assess the prevalence of ketosis, ketonuria and...

    Nora Luethi, Luca Cioccari, Marco Crisman, Rinaldo Bellomo in Critical Care (2016)

  12. Article

    Open Access

    Hemodynamic assessment of critically ill patients using a miniaturized transesophageal echocardiography probe

    Hemodynamic management in intensive care patients guided by blood pressure and flow measurements often do not sufficiently reveal common hemodynamic problems. Trans-esophageal echocardiography (TEE) allows for...

    Luca Cioccari, Hans-Rudolf Baur, David Berger, Jan Wiegand, Jukka Takala in Critical Care (2013)